글로벌 종양 추적 시스템 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 종양 추적 시스템 시장

종양 추적 시스템 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 2028년까지 시장이 51억 9,742만 달러에 도달할 것으로 추정하고, 상기 예측 기간 동안 4.65%의 CAGR로 성장할 것으로 분석했습니다. 수많은 라이프스타일 장애의 부담 증가가 종양 추적 시스템 시장을 주도합니다.

종양 추적은 주변의 건강한 조직을 손상시키지 않고 충분한 방사선량을 전달하는 방사선 요법 치료에 매우 중요하다고 정의됩니다. 종양 추적 시스템은 환자 신체의 종양을 추적하는 데 사용되며, 주변의 건강한 조직을 손상시키지 않고 충분한 방사선량을 전달하는 방사선 요법에 중요합니다.

전 세계적으로 대규모 환자 기반이 시장 성장을 가속화하는 중요한 요인이며, 질병에 대한 높은 인식, 암 치료를 선택하는 사람들의 비율 증가, 전 세계적으로 전립선암의 높은 유병률, 기술 발전의 증가, 암 연구 및 자금 지원의 증가는 종양 추적 시스템 시장을 주도하는 주요 요인 중 하나입니다. 또한, 의료 기기의 기술 발전과 현대화의 증가 , 진료 시점 진단의 필요성 증가, 개인화된 의학에 대한 수요 증가는 2021-2028년 예측 기간 동안 종양 추적 시스템 시장에 새로운 기회를 창출할 것입니다.

그러나 높은 자본 투자와 샘플 수집 및 보관과 관련된 기술적 문제는 시장 성장을 방해하는 주요 요인 중 하나이며, 위에서 언급한 예측 기간 동안 종양 추적 시스템 시장 성장에 더욱 어려움을 겪을 것입니다.

Tumor tracking systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on tumor tracking systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Tumor Tracking Systems Market Scope and Market Size

Tumor tracking systems market is segmented on the basis of device type, application and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of device type, tumor tracking systems market t is segmented into direct tumor tracking systems, respiratory tracking systems and others.
• Based on application, the tumor tracking systems market is segmented into prostate cancer, lung cancer, breast cancer and others.
• The tumor tracking systems market is also segmented on the basis of end-user into hospitals, cancer research institutes, ambulatory surgical centers and others.

Tumor Tracking Systems Market Country Level Analysis

Tumor tracking systems market is analysed and market size insights and trends are provided by country, device type, application and end-users as referenced above.

The countries covered in the tumor tracking systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tumor tracking systems market due to high awareness regarding the disease, rise in the percentage of people opting for cancer treatment, high prevalence rate of prostate cancer across the world, rise in the technological advancements and rise in the cancer research and funding in this region. Asia-Pacific is the expected region in terms of growth in tumor tracking systems market due to high awareness regarding the disease, rise in the percentage of people opting for cancer treatment and high prevalence rate of prostate cancer in this region.

The country section of the tumor tracking systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Tumor tracking systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for tumor tracking systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tumor tracking systems market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Tumor Tracking Systems Market Share Analysis

Tumor tracking systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tumor tracking systems market.

종양 추적 시스템 시장 보고서에서 다루는 주요 기업으로는 Illumina, Inc., QIAGEN, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Caris Life Sciences, Genomic Health, Helomics Corp, NanoString, Sysmex Corporation, Guardant Health, FOUNDATION MEDICINE, INC, F. Hoffmann-La Roche Ltd, GenScript, Tempus, Boreal Genomics, Inc., Perthera, Inc., Agendia, OmniSeq Corporation, HistoGeneX NV 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-63142